Peptide RX

back to claim graph

proof receipt / target

VEGFR2

Vascular endothelial growth factor receptor 2

grade B status recovery receipt ccb367ee010b proof 33%

what this node claims

VEGFR2

Vascular endothelial growth factor receptor 2

Open source surface

vertical proof spine

  1. 01 VEGFR2 target / grade B / 70% 1 debt
  2. 02 KDR WT fold / grade B / 62% 2 debt

evidence / risk instrument

44%
thin proof
structure evidence gates risk export lineage 44
low debt pressure 21%
28%structuredebt
pLDDT pending
78%evidenceusable
grade B
0%gatesdebt
0/5 gates
100%riskstrong
0 hard flags
22%exportdebt
no export
33%lineagedebt
incomplete spine

proof completeness

33% missing alphafold_metric, candidate, finding, export
  1. 01 target
  2. 02 fold
  3. 03 alphafold metric
  4. 04 candidate
  5. 05 finding
  6. 06 export

Metrics and receipt inputs

binding partners
    context annotations
    0
    family
    RTK
    functional sites
      gene symbol
      KDR
      go terms
        uniprot
        P35968

        AlphaFold metrics visual

        Confident backbone model

        71.1

        1356 residues / min 24.44 / max 97.69 / source alphafold db

        PAE matrix for linked target
        Very high 23.5% 318 residues / >=90
        Confident 43.4% 589 residues / 70-89
        Low 7.6% 103 residues / 50-69
        Very low 25.5% 346 residues / <50

        usable fold context with explicit model-confidence limits

        Near-complete coverage / observed 1356 of 1356 residues.

        • residues 1240-1356 / mean 32.49
        • residues 1167-1236 / mean 32.26
        • residues 937-999 / mean 31.96
        • residues 785-822 / mean 39.87
        proof debt register

        Visible limits, not hidden cleanup.

        21%

        Peptide RX keeps unresolved proof debt attached to the public receipt. Some debts should be resolved; redaction and research-use boundaries should stay visible.

        medium missing functional-site annotations link target annotation, GO term, or binding-site context
        low computational-only status add independent evidence, challenge result, or witness review before strengthening
        medium no candidate yet leave visible until a stronger public receipt resolves it

        weakness and challenge edges

        What would stop this from becoming stronger.

        debt severity export claim strength next proof needed
        missing functional-site annotations medium visible weakens link target annotation, GO term, or binding-site context
        computational-only status low visible watch add independent evidence, challenge result, or witness review before strengthening
        no candidate yet medium visible weakens leave visible until a stronger public receipt resolves it

        what supports it

        No upstream proof edge yet.

        what it supports

        target has structure prediction target:ce831bd5-507f-49e0-837b-bd8fa4acdd10 -> fold:000266a5-9129-4f8f-b9d5-e0216c573655 folds_to / B / 0.711

        Research-use boundary

        This receipt describes public computational research state. It does not expose raw candidate sequences and does not make a clinical claim.